Lung Cancer
News
Two trials spotlight atezolizumab activity in advanced lung cancer
Key clinical point: Atezolizumab is clinically active in advanced lung cancer and higher PD-L1 expression correlated with improved response and...
News
Lung adenocarcinoma can harbor both ALK fusions and EGFR driver mutations
Key clinical point: Tumor cells within the same primary tumor were found to harbor both ALK fusions and EGFR driver mutations. Major finding: In...
Conference Coverage
Actionable mutations are highly prevalent in young lung cancer patients
Genomic testing is paramount when lung cancer occurs before age 40.
Conference Coverage
Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patients
teaser
Community Translations
Nivolumab: first immunotherapy approved for lung cancer
News
Is Skip N2 metastasis its own category?
teaser
Conference Coverage
Recent quitters win big in lung screening trials
Key clinical point: Quitting smoking results in a significant reduction in all-cause mortality among heavy smokers taking part in screening...
David Henry's JCSO Podcast
David Henry's JCSO podcast, August 2015
News
SWITCH 1 supports carboplatin-vinorelbine regimen in early NSCLC
An adjuvant regimen of carboplatin plus vinorelbine is well tolerated and efficacious in patients who have undergone complete resection of early...
News
Vaccines targeting MUC1 show activity against NSCLC
Key clinical point: Therapeutic vaccines targeting MUC1 show clinical activity against non–small cell lung cancer. Major finding: Overall survival...
Conference Coverage
MAPS: Bevacizumab prolongs survival in mesothelioma
Key clinical point: Adding bevacizumab to pemetrexed and cisplatin prolonged overall survival by almost 3 months. Major finding: Median overall...